Myomo Completes IPO, The First Reg A+ Offering To List On The NYSEBlog
sclerosis (MS), or who have suffered a stroke or have nerve injuries. ...
You are here
Page not found
Search results
GenprexOffering
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
QUARAOffering
Convertible note pays 10% per year. Minimum investment $10,000
Advantages of using Reg A+ to raise up to $75 Mill per year of capital and provide liquidity (Short Video)Blog
of comments back from the SEC reduced the SEC seems to like Regulation A+, ...
Bringing Affordable Insulin to the Market- An Interview With BiologX CEO- Interactive Clickable VideoBlog
Rod Turner: I want to comment on what those alternative trading systems are for, for the audience has benefit. And then I'd like you to comment ... company. Rod Turner: Let me, I want to comment on that. Not commenting now ...
Choosing The Optimum Valuation For Your Reg CF, Reg A+, Reg D, and Rule 144A® Capital Raise; Interactive Clickable VideoBlog
to the legal disclaimers in the, in the comments section about Manhattan street ... on those companies, so I'm not going to comment beyond that. Essentially ... their price. So I'm sorry. I can't comment on that. Why do I hear from ...
Alternative Funding Vehicle for Medtech Startups: Raising Capital through Regulation A+- Interactive Clickable VideoBlog
that you have. Please feel free to post questions in the comment in the chat ... because I'm seeing the comments coming in order to make sure, you know, ...
Manhattan Street FundOffering
Private offering for wealthy investors
CubCrafters Webinar: Q&A Session for Investors, Customers, and FansBlog
if you have any comments you would like to make in closing, I'd ... for the time today. Rod Turner: Brad, do you have any comments that you'd ...
Alternative, uncorrelated investments. Can you Earn 20% Per Year with low volatility?- Interactive Clickable VideoBlog
value here in terms of what value or pardon me, please add your comments to this is other items that I've missed. And what comments would you like to put ... but any questions, please post them now? Comments, suggestions, welcome ...